Drug Approval | April 12, 2023
Zydus receives final approval from USFDA for Tavaborole Topical Solution
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.
Urges everyone to follow COVID Appropriate Behaviour and curb any misinformation
To enable company to be future-ready by tapping potential in CDMO space
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
Bourgoin early development hub broadens offerings for oral solid dose formulations
Subscribe To Our Newsletter & Stay Updated
